# MoonLake Immunotherapeutics: Form 8-K, filed Jun 26, 2023

- Company: [MoonLake Immunotherapeutics](/companies/mltx.md) (CIK 1821586)
- Form: 8-K
- Filed: 2023-06-26
- Accepted by EDGAR: Jun 26, 2023, 08:45 ET
- Period: 2023-06-26
- Accession: 0001628280-23-023381
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1821586/000162828023023381/mltx-20230626.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1821586/000162828023023381/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1821586/000162828023023381/mltx-20230626.htm

Filed Jun 26, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-023381. Last ingested by Listed: Nov 4, 2026, 07:34 ET. No prices; not investment advice.
